Australia delays response on allowing third-party conformity assessment
This article was originally published in RAJ Devices
Executive Summary
Medical device manufacturers waiting to hear whether Australia’s Therapeutic Goods Administration plans to allow them to use third-party conformity assessment bodies for certifying their quality systems are facing further delays1,2.
You may also be interested in...
EU Clinical Trial Portal Requires Rethink On Balancing Business Interests & Transparency
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.
Launch Of EU Clinical Trial Portal Moves A Step Closer
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.
EU Mandates Monthly Safety Summaries For Approved COVID-19 Vaccines
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.
Need a specific report? 1000+ reports available
Buy Reports